Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000437766 | SCV000519330 | benign | not specified | 2016-01-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001513624 | SCV001721273 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001702648 | SCV001933355 | benign | Hennekam lymphangiectasia-lymphedema syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001702647 | SCV001933356 | benign | Van Maldergem syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000437766 | SCV004233445 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied by a panel of primary immunodeficiencies. Number of patients: 42. Only high quality variants are reported. |
Clinical Genetics, |
RCV000437766 | SCV001920253 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000437766 | SCV001971335 | benign | not specified | no assertion criteria provided | clinical testing |